Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia
Authors:
Open Access
- 5 July 2007
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 21 (9) , 2071-2072
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Essential thrombocythemia: scientific advances and current practiceCurrent Opinion in Hematology, 2006
- Hydroxyurea Compared with Anagrelide in High-Risk Essential ThrombocythemiaNew England Journal of Medicine, 2005
- Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyBlood, 2005
- Busulfan Versus Hydroxyurea in the Treatment of Polycythemia Vera (PV) and Essential Thrombocythemia (ET)American Journal of Clinical Oncology, 1998
- Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p DeletionBlood, 1998
- Primary thrombocythaemia treated with busulphanBritish Journal of Haematology, 1986